Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Diffusion Pharmaceuticals Inc (DFFN)

0.83   0.035 (4.34%) 09-27 22:15
Open: 0.81 Pre. Close: 0.7955
High: 0.8673 Low: 0.772
Volume: 1,575,119 Market Cap: 53M
Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. The company is headquartered in Charlottesville, Virginia and currently employs 10 full-time employees. The firm is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The firm's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC) is used in various cancer types, in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The firm's Diffusion's technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate, TSC, with standard-of-care radiation and chemotherapy regimens, thus effecting a better patient survival outcome without the addition of harmful side effects. Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types, with an initial focus on primary brain cancer (glioblastoma or GBM), pancreatic cancer, and brain metastases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.872 - 0.878 0.878 - 0.883
Low: 0.757 - 0.764 0.764 - 0.77
Close: 0.819 - 0.83 0.83 - 0.84

Technical analysis

as of: 2020-09-25 4:29:04 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.16     One year: 1.33
Support: Support1: 0.75    Support2: 0.62
Resistance: Resistance1: 0.99    Resistance2: 1.14
Pivot: 0.86
Moving Average: MA(5): 0.82     MA(20): 0.88
MA(100): 1.02     MA(250): 0.76
MACD: MACD(12,26): -0.05     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 23.46     %D(3): 23.87
RSI: RSI(14): 40.09
52-week: High: 1.97  Low: 0.21  Change(%): -55.1
Average Vol(K): 3-Month: 242966  10-Days: 131376

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
DFFN has closed above bottom band by 36.2%. Bollinger Bands are 48.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to DFFN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 25 Sep 2020
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Stock Jumped 72.67% Year-To-Date, What Analysts Expect Next? - Marketing Sentinel

Fri, 25 Sep 2020
Diffusion Pharmaceuticals (NASDAQ:DFFN) Creates a Treatment to Improve Oxygenation - The Wall Street Transcript

Thu, 24 Sep 2020
Are Shares Of Diffusion Pharmaceuticals Inc. (DFFN) Really Worth? - investmillion.com

Wed, 23 Sep 2020
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) on the Path to Ruin - The Oracle Dispatch

Tue, 15 Sep 2020
Diffusion Pharmaceuticals Inc. (DFFN) EPS is poised to hit -0.07 next quarter: How Investors Can Make It Count the Most? - News Daemon

Fri, 11 Sep 2020
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) is Waving the Bear Flag - The Oracle Dispatch

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64
Shares Float (M) 64
% Held by Insiders 0.23
% Held by Institutions 13.33
Shares Short (K) 847
Shares Short P. Month (K) 737

Stock Financials

EPS -0.536
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.510
Profit Margin
Operating Margin
Return on Assets (ttm) -28.7
Return on Equity (ttm) -49.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.196
Qtrly Earnings Growth
Operating Cash Flow (M) -11
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -1.55
PEG Ratio
Price to Book value 1.63
Price to Sales
Price to Cash Flow -4.73

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.